Abstract:Adrian Vasile Bota, 1, 2 Iulia Bogdan, 1– 3 David Vladut Razvan, 1, 2 Adrian Cosmin Ilie, 4 Raluca Tudor, 5 Mirela Florica Indries, 6 Andrei Nicolae Csep, 6 Iosif Marincu 1 1 Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania; 2 Doctoral School, "victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania; 3 Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania; 4 Department III Functional Sciences, Division of Public Health and Management, "Victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania; 5 Second Discipline of Neurology, "victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania; 6 Department of Psycho-Neuroscience and Recovery, University of Oradea, Faculty of Medicine and Pharmacy, Oradea, 410087, Romania Correspondence: Raluca Tudor; Andrei Nicolae Csep, Email ; Background: This study explores the longitudinal psychosocial impact of Long-COVID syndrome, also known as Post-COVID-19 syndrome, characterized by enduring symptoms after coronavirus disease (COVID-19) infection, over the years 2020, 2021, and 2022. It aimed to examine the variations in depression, anxiety, and quality of life among Post-COVID-19 patients during these years, hypothesizing significant inter-year differences reflecting the pandemic's evolving influence. Methods: Conducted at Victor Babes Hospital for Infectious Diseases and Pulmonology, Romania, this cross-sectional research involved 324 patients diagnosed with mild to moderate COVID-19, assessed six months post-hospitalization. Standardized instruments, namely Short Form (SF-36) for quality of life, Generalised Anxiety Disorder Assessment (GAD-7) for anxiety, and Patient Health Questionnaire (PHQ-9) for depression, were utilized. Results: The study observed a consistent average patient age of around 55 years across the years. A notable increase in COVID-19 vaccination rates was recorded, rising from 20.9% in 2020 to over 70% in 2022 (p< 0.001). Trends in key post-COVID symptoms like fatigue and cognitive issues varied over the years. Importantly, there was a consistent decrease in feelings of sadness or depression, with scores declining from 7.3 in 2020 to 4.8 in 2022 (p< 0.001). The SF-36 survey indicated a steady improvement in overall health, reaching 55.8± 7.1 in 2022 (p=0.035). Both GAD-7 and PHQ-9 scores showed significant reductions in anxiety and depression over the years, with p-values of 0.030 and 0.031, respectively. Factors such as smoking status, substance use, and the initial severity of COVID-19 infection were significantly associated with depression levels. Conclusion: The findings suggest that despite persistent physical symptoms, Long-COVID patients experienced enhancements in mental well-being and quality of life over the studied period. The increasing vaccination rates might have contributed to this improvement. Addressing modifiable risk factors like smoking and substance use could further optimize post-COVID care and mental health outcomes. Keywords: SARS-CoV-2, COVID-19, long-COVID, quality of life, post, acute COVID The novel severe-acute-respiratory-syndrome-related coronavirus (SARS-CoV-2) emerged in late 2019 and rapidly evolved into a global pandemic. Beyond the immediate health implications and mortality rates associated with the acute phase of the virus, a significant portion of individuals who recover from the initial infection 1 continue to experience lingering symptoms, commonly referred to as "Long-COVID" or "Post-COVID" Syndrome. 2–6 Other studies highlight the challenge of diagnosing individuals who have not received a confirmed SARS-CoV-2 diagnosis, complicating the understanding and treatment of "long-haulers". Moreover, these studies underscore the importance of recognizing both intrinsic and extrinsic factors, along with the impact of hospitalization, in influencing the progression and persistence of post-COVID symptoms. 7,8 Historically, viral pandemics have not only posed immediate threats but have also been accompanied by longer-term health implications. The nature and course of these post-viral syndromes often remain elusive and are subject to ongoing research. 9–11 With coronavirus disease (COVID-19), initial evidence suggests that Long-COVID symptoms can encompass a wide range of health issues, with neurological and psychological manifestations being among the mo -Abstract Truncated-

Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Exploring social determinants of health and their impacts on self-reported quality of life in long COVID-19 patients

Long COVID prevalence and impact on quality of life 2 years after acute COVID-19

Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

Main Predictors of Decreasing in Quality of Life in Patients With Post-COVID-19: A Cross-Sectional Study

Attributes and predictors of long COVID

Impact of Long COVID on Health-Related Quality of Life Among Patients After Acute COVID-19 Infection: A Cross-Sectional Study

Modeling the burden of long COVID in California with quality adjusted life-years (QALYS)

Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and Long COVID infection

Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care

Long Covid: a global health issue - a prospective, cohort study set in four continents

A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome

Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization

Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela

Gender differences in symptomatology, socio-demographic information and quality of life in Spanish population with long COVID condition: a cross-sectional study

Health-related Quality of Life following Mild COVID-19 Illness

Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data

Long-Term Effect on Health-Related Quality of Life in Patients With COVID-19 Requiring Hospitalization Compared to Non-hospitalized COVID-19 Patients and Healthy Controls

Memory, Emotion, and Quality of Life in Patients with Long COVID-19

Risk and protective factors for the severity of long COVID - A network analytic perspective